Researcher Spotlight: Ruth Alonso-Alonso, PhD THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Oliver W. Press, MD, PhD Memorial Fellow Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive form of peripheral T-cell lymphoma. Therapeutic options for AITL are…
Researcher Spotlight: Wen-Hsuan Wendy Lin, MD, PhD COLUMBIA UNIVERSITY Peripheral T-cell lymphomas (PTCL) represent a group of aggressive blood cancers with poor outcomes. A common phenomenon in PTCL is the development of a proinflammatory microenvironment, in which lymphoma cells recruit…
Researcher Spotlight: Zachary Epstein-Peterson, MD MEMORIAL SLOAN KETTERING CANCER CENTER Peripheral T-cell lymphomas are a rare and challenging group of malignancies to treat. Mutations in the isocitrate dehydrogenase 2 (IDH2) enzyme have been identified in a subgroup of patients with…
Researcher Spotlight: Neha Mehta-Shah, MD Washington University in Saint Louis Peripheral T-cell lymphomas (PTCL) are a rare group of lymphomas that are commonly treated with combination chemotherapy, followed by autologous stem cell transplant for patients with a good response. However,…